Drug recall · April 12, 2017
Adalat CC recall
Why: Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Adalat CC (nifedipine) Extended-Release Tablets, 30 mg, 100-count bottles, Rx Only, Manufactured for Almatica Pharma Inc. Pine Brook, NJ 07058 USA, NDC 5242749401
- Lots / codes
Lot #: BXHBJD1A, Exp. 10/2018
- Quantity
- N/A
- Company
- Alvogen, Inc, Pine Brook, NJ
- Distribution
- Nationwide
- Initiated
- March 7, 2017 · Voluntary: Firm initiated
- Classified
- April 4, 2017
- Reported
- April 12, 2017
- Ended
- December 15, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Nifedipine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.